NeuroBo Pharmaceuticals, Inc. NRBO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

There have been 50 recent insider transactions recorded for NeuroBo Pharmaceuticals, Inc. (NRBO), including 35 buys and 4 sells. Total insider buying was valued at $31.94M and total insider selling at $42.81K.

Notable insiders with recent activity include Dong-a St Co., Ltd, Kim Hyung Heon, Strickland D Gordon. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — NRBO

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2024-09-18	Dong-a St Co., Ltd	10 Percent Owner	Informative Buy	2,544,530	$3.93	$10M	2,544,530
2024-09-12	Dong-a St Co., Ltd	10 Percent Owner	Informative Sell	407	$3.75	$1.53K	5,347,792
2024-08-11	Kim Hyung Heon	CEO & President	Tax Withholding of RSU	11,467	$3.60	$41.28K	66,666
2024-06-23	Dong-a St Co., Ltd	10 Percent Owner	Informative Buy	2,544,530	$3.13	$7.96M	5,348,229
2024-06-23	Dong-a St Co., Ltd	10 Percent Owner	Informative Buy	2,544,530	$3.93	$10M	5,348,229
2024-06-07	Strickland D Gordon	Director	RSU Award	5,051	-	-	17,552
2024-06-07	Koven Andrew I	Director	RSU Award	5,051	-	-	17,552
2024-06-07	Glickman Mark A	Director	RSU Award	5,051	-	-	9,740
2024-06-07	Groves Jason L	Director	RSU Award	5,051	-	-	17,552
2024-06-07	Tursi James Patrick	Director	RSU Award	5,051	-	-	9,072
2024-06-07	Salsbury Michael	Director	RSU Award	5,051	-	-	17,552
2024-03-01	Woodworth Marshall H	Chief Financial Officer	RSU Award	33,496	-	-	33,496
2023-12-01	Tursi James Patrick	Director	RSU Award	25,000	-	-	25,000
2023-11-01	Tursi James Patrick	Director	Unknown	-	-	-	-
2023-10-27	Woodworth Marshall H	Officer	Unknown	-	-	-	-
2023-08-11	Kim Hyung Heon	CEO & President	RSU Award	625,064	-	-	625,064
2023-07-27	Strickland D Gordon	Director	RSU Award	87,500	-	-	87,500
2023-07-27	Koven Andrew I	Director	RSU Award	87,500	-	-	87,500
2023-07-27	Glickman Mark A	Director	RSU Award	25,000	-	-	25,000
2023-07-27	Groves Jason L	Director	RSU Award	87,500	-	-	87,500
2023-07-27	Kim Na Yeon	10 Percent Owner	RSU Award	87,500	-	-	88,959
2023-07-27	Salsbury Michael	Director	RSU Award	87,500	-	-	87,500
2023-05-11	Glickman Mark A	Director	Unknown	-	-	-	-
2023-01-12	Hooker Joseph	Officer	Unknown	-	-	-	-
2022-11-16	Goldman Sachs Group Inc	Director	Unknown	-	-	-	1,220,502
2022-07-26	Kim Na Yeon	Director	Other (Sell)	1,445,267	-	-	2,890,533
2022-07-26	E&healthcare Investment Fund Ii	Director	Other (Sell)	1,445,267	-	-	2,890,533
2022-07-26	Kim Na Yeon	10 Percent Owner	Other (Buy)	4,671	-	-	4,671
2022-06-09	Strickland D Gordon	Director	RSU Award	20,000	-	-	20,000
2022-06-09	Koven Andrew I	Director	RSU Award	20,000	$0.47	$9.45K	20,000
2022-06-09	Salsbury Michael	Director	RSU Award	20,000	$0.47	$9.45K	20,000
2022-06-09	Kang Richard	Director	RSU Award	20,000	-	-	20,000
2022-06-09	Kim Hyung Heon	Director	RSU Award	20,000	-	-	20,000
2022-06-09	Groves Jason L	Director	RSU Award	20,000	$0.47	$9.45K	20,000
2022-06-09	Kim Na Yeon	Director	RSU Award	20,000	-	-	20,000
2022-01-27	Strickland D Gordon	Director	Unknown	-	-	-	-
2022-01-27	Strickland D Gordon	Director	RSU Award	40,000	$1.02	$40.8K	40,000
2021-11-03	Price Ben Gil	Officer	Unknown	-	-	-	-
2021-11-03	Price Ben Gil	CEO and President	RSU Award	616,666	$2.04	$1.26M	616,666
2021-09-02	Koven Andrew I	Director	RSU Award	60,000	$4.52	$271.2K	60,000
2021-07-09	Koven Andrew I	Director	Unknown	-	-	-	-
2021-07-09	Kim Hyung Heon	Director	Unknown	-	-	-	-
2020-12-31	Bakshi Akash	SVP and COO	Unknown	-	-	-	-
2020-12-31	Bakshi Akash	SVP and COO	RSU Award	29,013	-	-	29,013
2020-09-01	Swirsky Douglas J	Director	Unknown	-	-	-	-
2020-09-01	Swirsky Douglas J	Director	RSU Award	60,000	$6.04	$362.4K	60,000
2020-01-13	Jeong Tae Heum	Director	RSU Award	60,000	$8.39	$503.4K	60,000
2020-01-13	Groves Jason L	Director	RSU Award	60,000	$8.39	$503.4K	60,000
2020-01-13	Gullans Steven R. Ph.d.	Director	RSU Award	60,000	$8.39	$503.4K	60,000
2020-01-13	Oh Jeong Gyun	10 Percent Owner	RSU Award	60,000	$8.39	$503.4K	60,000

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry